Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...

Neuropathic pain, defined as pain caused by a lesion or disease of the somatosensory nervous system, does not act as a signal to warn the body of damage as acute pain does, and thus it does not have a ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release. The acquisition expands Globus Medical’s reach in the musculoskeletal market ...

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in musculoskeletal solutions. The deal, which was initially announced in ...

More Information About Nevro Corp. Nevro Corp is a medical device company specializing in the development and commercialization of innovative solutions for chronic pain management ...

REDWOOD CITY, CA – Nevro Corp , a medical device company with annual revenues of $408.52 million and a market capitalization of $221.21 million, announced on Monday that it has completed a merger with ...